Scientists test new obesity Drug's heart safety
NCT ID NCT06200467
Summary
This study tested whether a new weight-loss medicine called survodutide (BI 456906) is safe for the heart. It involved 110 otherwise healthy adults with overweight or obesity who received weekly injections for about 30 weeks. Researchers closely monitored participants' heart rhythms to check for any unwanted effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CRS Clinical Research Services Mannheim GmbH
Mannheim, 68167, Germany
Conditions
Explore the condition pages connected to this study.